Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Valued at a market cap of $395 billion, Johnson & Johnson (JNJ) operates in the healthcare sector, encompassing pharmaceuticals, medical devices, and consumer products. The New Brunswick, New Jersey-based company excels with its diversified business model, robust R&D investment, and global reach in various therapeutic and consumer health areas. 

Shares of the healthcare juggernaut have underperformed the broader market over the past 52 weeks. JNJ has declined 4.6% during this period, contrasting with the S&P 500 Index's ($SPX) robust rally of 15.8%. In 2024, JNJ shares appreciated by 2.9%, yet the stock continued to lag behind SPX's 8.7% gain on a YTD basis.